Waters Parkerson & Company Lifted Devon Energy (DVN) Stake; Arrow Financial Position In Biogen (BIIB) Was Boosted

Biogen Inc. (NASDAQ:BIIB) Logo

Arrow Financial Corp increased its stake in Biogen Inc (BIIB) by 1538.46% based on its latest 2018Q3 regulatory filing with the SEC. Arrow Financial Corp bought 1,000 shares as the company’s stock declined 6.12% with the market. The institutional investor held 1,065 shares of the biological products (no diagnostic substances) company at the end of 2018Q3, valued at $376,000, up from 65 at the end of the previous reported quarter. Arrow Financial Corp who had been investing in Biogen Inc for a number of months, seems to be bullish on the $65.81B market cap company. The stock increased 0.68% or $2.19 during the last trading session, reaching $326.63. About 1.22M shares traded. Biogen Inc. (NASDAQ:BIIB) has declined 0.04% since January 10, 2018 and is downtrending. It has underperformed by 0.04% the S&P500. Some Historical BIIB News: 05/04/2018 – Biogen and Samsung Bioepis Agree to Settlement with AbbVie Allowing Commercialization of IMRALDI™ (Adalimumab Biosimilar) in Europe; 24/04/2018 – BIOGEN INC QTRLY NON-GAAP DILUTED EPS $6.05; 14/05/2018 – Primecap Management Adds Siemens Healthineers, Cuts Biogen; 13/04/2018 – Brightwire: Biogen likely to exercise option to raise stake in Samsung Bioepis, insiders say; 23/04/2018 – New SPINRAZA┬« (nusinersen) Data Unveiled at AAN Annual Meeting Show Continued Improvement in Motor Function for Broad Age Rang; 20/04/2018 – $BIIB $IONS Interesting slide on antisense and gene therapy being “Complementary”, “Combination / sequential”. Will see if Biogen answer any question re $AVXS; 24/04/2018 – Biogen Reports Quarterly Revenues of $3.1 Billion; 01/05/2018 – Biogen Licensed Worldwide Rights to Aducanumab From Neurimmune in 2007; 24/04/2018 – Biogen quarterly profit jumps on higher Spinraza sales; 20/04/2018 – BIOGEN – IN COLLABORATION BIOGEN WILL BE RESPONSIBLE FOR AND PAY FOR NON-CLINICAL STUDIES, CLINICAL DEVELOPMENT, MANUFACTURING, AND COMMERCIALIZATION

Waters Parkerson & Company increased its stake in Devon Energy Corp (DVN) by 14.66% based on its latest 2018Q3 regulatory filing with the SEC. Waters Parkerson & Company bought 19,610 shares as the company’s stock declined 35.15% with the market. The institutional investor held 153,380 shares of the oil & gas production company at the end of 2018Q3, valued at $6.13 million, up from 133,770 at the end of the previous reported quarter. Waters Parkerson & Company who had been investing in Devon Energy Corp for a number of months, seems to be bullish on the $12.09 billion market cap company. The stock increased 1.10% or $0.28 during the last trading session, reaching $25.83. About 12.58M shares traded or 51.29% up from the average. Devon Energy Corporation (NYSE:DVN) has declined 29.29% since January 10, 2018 and is downtrending. It has underperformed by 29.29% the S&P500. Some Historical DVN News: 02/04/2018 – Fidelity Mid Cap Value Adds Ametek, Exits Devon; 07/03/2018 – Devon Energy Sells Southern Portion of Barnett Shale Position for $553M; 04/05/2018 – Devon at Citi Global Energy & Utilities Conference May 16; 20/03/2018 – RPT-A small oil field in Oklahoma is seeing big bets from producers; 20/04/2018 – DJ Devon Energy Corporation, Inst Holders, 1Q 2018 (DVN); 14/03/2018 – Oil majors give in to investors with share buyback spree; 01/05/2018 – Devon Energy: On Pace to Reduce G&A, Interest Costs by $175M Annually; 07/03/2018 – DEVON ENERGY REPORTS TENDER OFFERS FOR UP TO $1.0B AGGREGATE BU; 16/05/2018 – Moody’s: Devon Energy Outlook Is Stable; 01/05/2018 – Devon Energy: Repurchased 6.2M Shrs for $204M

Waters Parkerson & Company, which manages about $1.24 billion and $1.22B US Long portfolio, decreased its stake in Nike Inc Cl B (NYSE:NKE) by 9,612 shares to 363,866 shares, valued at $30.83 million in 2018Q3, according to the filing. It also reduced its holding in Dominion Energy Inc Com (NYSE:D) by 4,328 shares in the quarter, leaving it with 20,858 shares, and cut its stake in Visa Inc Com Cl A (NYSE:V).

Investors sentiment decreased to 0.73 in 2018 Q3. Its down 0.10, from 0.83 in 2018Q2. It worsened, as 51 investors sold DVN shares while 256 reduced holdings. 71 funds opened positions while 154 raised stakes. 360.10 million shares or 9.61% less from 398.41 million shares in 2018Q2 were reported. Ingalls Snyder Ltd Liability owns 0.07% invested in Devon Energy Corporation (NYSE:DVN) for 43,830 shares. Duncker Streett And Com reported 1,139 shares. Moreover, South State Corporation has 0.12% invested in Devon Energy Corporation (NYSE:DVN) for 29,658 shares. Employees Retirement Association Of Colorado has 90,391 shares for 0.02% of their portfolio. Moreover, Evercore Wealth Ltd Co has 0.01% invested in Devon Energy Corporation (NYSE:DVN) for 11,306 shares. Hightower Advsrs Lc holds 0.03% of its portfolio in Devon Energy Corporation (NYSE:DVN) for 97,794 shares. Kingdon Mgmt Ltd Liability Corporation has invested 0.56% in Devon Energy Corporation (NYSE:DVN). Schroder Inv Mngmt Gru, a Maine-based fund reported 218,542 shares. Ferguson Wellman Capital Management, Oregon-based fund reported 12,037 shares. Blume has invested 3.62% in Devon Energy Corporation (NYSE:DVN). Texas Permanent School Fund holds 114,219 shares or 0.06% of its portfolio. Strategy Asset Managers Limited Liability holds 10,547 shares. Voya Inv Mgmt Ltd Company holds 0.02% of its portfolio in Devon Energy Corporation (NYSE:DVN) for 242,565 shares. Moore Capital Mgmt Lp invested in 0.55% or 647,000 shares. State Board Of Administration Of Florida Retirement owns 716,617 shares or 0.07% of their US portfolio.

Among 40 analysts covering Devon Energy Corporation (NYSE:DVN), 24 have Buy rating, 0 Sell and 16 Hold. Therefore 60% are positive. Devon Energy Corporation had 153 analyst reports since July 21, 2015 according to SRatingsIntel. On Monday, January 29 the stock rating was maintained by Stifel Nicolaus with “Buy”. Stifel Nicolaus maintained the stock with “Buy” rating in Monday, April 23 report. RBC Capital Markets maintained Devon Energy Corporation (NYSE:DVN) on Friday, April 13 with “Buy” rating. The firm earned “Buy” rating on Wednesday, February 21 by Susquehanna. The company was maintained on Tuesday, July 4 by RBC Capital Markets. Cowen & Co maintained Devon Energy Corporation (NYSE:DVN) on Wednesday, September 27 with “Buy” rating. Piper Jaffray maintained the shares of DVN in report on Wednesday, April 18 with “Hold” rating. As per Wednesday, October 18, the company rating was maintained by Morgan Stanley. On Thursday, February 22 the stock rating was maintained by Bernstein with “Hold”. The rating was maintained by BMO Capital Markets with “Buy” on Wednesday, June 21.

More notable recent Devon Energy Corporation (NYSE:DVN) news were published by: Seekingalpha.com which released: “Why Devon Should Exit The Barnett – Seeking Alpha” on October 08, 2018, also Finance.Yahoo.com with their article: “Jim Cramer Shares His Thoughts On Kinder Morgan, Devon Energy And More – Yahoo! Finance News” published on December 19, 2018, Seekingalpha.com published: “Highlights From Devon’s Well-Received Q1 Report – Seeking Alpha” on May 04, 2018. More interesting news about Devon Energy Corporation (NYSE:DVN) were released by: Fool.com and their article: “This Oil Company Is Buying Back Its Stock as Fast as It Can – Motley Fool” published on September 17, 2018 as well as Seekingalpha.com‘s news article titled: “Devon Energy forecasts Q3 production gain, capex below guidance – Seeking Alpha” with publication date: October 16, 2018.

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Seekingalpha.com which released: “Biogen down 5%, sell-siders soften outlook – Seeking Alpha” on December 18, 2018, also Nasdaq.com with their article: “Alkermes, Biogen Submit NDA to FDA for Multiple Sclerosis Drug – Nasdaq” published on December 18, 2018, Streetinsider.com published: “Biogen (BIIB) Applauds Quebec Decision to Cover SPINRAZA for broad population of SMA Patients – StreetInsider.com” on December 20, 2018. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Investorplace.com and their article: “5 Pharma Stocks That Could Cure Ailing Portfolios in 2019 – Investorplace.com” published on December 12, 2018 as well as Seekingalpha.com‘s news article titled: “Biogen teams up with C4 Therapeutics in neurology – Seeking Alpha” with publication date: January 04, 2019.

Arrow Financial Corp, which manages about $476.23 million US Long portfolio, decreased its stake in Salesforce.Com (NYSE:CRM) by 3,482 shares to 33,024 shares, valued at $5.25 million in 2018Q3, according to the filing. It also reduced its holding in Schlumberger Ltd (NYSE:SLB) by 7,558 shares in the quarter, leaving it with 7,454 shares, and cut its stake in Amazon.Com Inc (NASDAQ:AMZN).

Since September 26, 2018, it had 0 insider buys, and 1 insider sale for $350,000 activity.

Investors sentiment decreased to 1.01 in 2018 Q3. Its down 0.01, from 1.02 in 2018Q2. It turned negative, as 45 investors sold BIIB shares while 334 reduced holdings. 138 funds opened positions while 243 raised stakes. 167.21 million shares or 1.69% less from 170.10 million shares in 2018Q2 were reported. Aqr Capital Management Limited Liability Company has 0.83% invested in Biogen Inc. (NASDAQ:BIIB). Vident Invest Advisory Ltd Liability Com holds 0.03% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 2,298 shares. Dimensional Fund Advisors Limited Partnership reported 630,250 shares stake. Lowe Brockenbrough accumulated 1,003 shares or 0.05% of the stock. Waverton Investment Mgmt Ltd has invested 5.28% in Biogen Inc. (NASDAQ:BIIB). Lombard Odier Asset (Europe) Limited reported 0.05% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Fmr Llc, Massachusetts-based fund reported 4.32M shares. Hartford Fin Mngmt owns 115 shares. Amica Pension Fund Board Of Trustees holds 6,442 shares or 0.3% of its portfolio. Tudor Inv Corporation Et Al owns 18,462 shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh accumulated 0.08% or 3,715 shares. Sumitomo Mitsui Asset Management Co Limited holds 0.08% or 14,555 shares. Everence Capital Mngmt holds 0.33% or 4,668 shares. Welch And Forbes Llc invested 0.06% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Weiss Multi holds 14,746 shares.

Among 35 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 27 have Buy rating, 0 Sell and 8 Hold. Therefore 77% are positive. Biogen Idec Inc. had 147 analyst reports since July 23, 2015 according to SRatingsIntel. Bernstein upgraded the shares of BIIB in report on Monday, July 27 to “Outperform” rating. The stock has “Strong-Buy” rating by Raymond James on Tuesday, September 1. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Hold” rating by RBC Capital Markets on Wednesday, October 25. The firm has “Hold” rating given on Monday, October 30 by Robert W. Baird. The firm has “Buy” rating given on Tuesday, November 28 by Bernstein. The rating was maintained by Piper Jaffray on Thursday, January 18 with “Buy”. As per Tuesday, October 24, the company rating was maintained by Cantor Fitzgerald. As per Friday, March 2, the company rating was maintained by Guggenheim. The company was maintained on Wednesday, July 26 by BMO Capital Markets. Cowen & Co maintained Biogen Inc. (NASDAQ:BIIB) on Tuesday, October 24 with “Buy” rating.

Devon Energy Corporation (NYSE:DVN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.